跳至主要内容
临床试验/DRKS00026091
DRKS00026091已完成未知

I(chten)Fe(ls) trial on the intensity of the nocebo effect concerning potential adverse effects after covid-19 vaccination based on the elaborateness of the medical briefing - LIFe trial

Impfzentrum Lichtenfels0 个研究点目标入组 4,334 人开始时间: 2022年5月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
4,334

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Only patients that were willing and able to give consent are included in this study.

排除标准

  • Patients that were not willing or unable to give consent were not included in this study.

研究者

发起方
Impfzentrum Lichtenfels

相似试验